• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An individualized left ventricular lead-targeting strategy improves long-term survival of cardiac resynchronization therapy patients and influences the benefit of the implantable cardioverter-defibrillator: a long-term follow-up of the TARGET study.

作者信息

Barra Sergio, Yu Emma, Khan Fakhar, Dutka David, Virdee Munmohan

机构信息

aCardiology Department, Papworth Hospital NHS Foundation Trust bDepartment of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge cCardiology Department, University College London Hospitals NHS Foundation Trust, London, UK.

出版信息

J Cardiovasc Med (Hagerstown). 2017 Jul;18(7):553-555. doi: 10.2459/JCM.0000000000000396.

DOI:10.2459/JCM.0000000000000396
PMID:27136703
Abstract
摘要

相似文献

1
An individualized left ventricular lead-targeting strategy improves long-term survival of cardiac resynchronization therapy patients and influences the benefit of the implantable cardioverter-defibrillator: a long-term follow-up of the TARGET study.个体化左心室导联靶向策略可提高心脏再同步治疗患者的长期生存率，并影响植入式心律转复除颤器的获益：TARGET研究的长期随访
J Cardiovasc Med (Hagerstown). 2017 Jul;18(7):553-555. doi: 10.2459/JCM.0000000000000396.
2
Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.心脏复律除颤器或心脏再同步治疗接受者的并发症：来自西里西亚中心除颤器登记处的见解。
Cardiol J. 2017;24(5):515-522. doi: 10.5603/CJ.a2016.0092. Epub 2016 Oct 13.
3
Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.左束支传导阻滞的轻度心力衰竭患者接受心脏再同步治疗的长期预后的性别差异
J Am Heart Assoc. 2015 Jun 29;4(7):e002013. doi: 10.1161/JAHA.115.002013.
4
Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.在心脏再同步治疗中添加植入式心脏复律除颤器与缺血性心肌病患者的长期生存率提高相关，但与非缺血性心肌病患者无关。
Europace. 2016 Mar;18(3):413-9. doi: 10.1093/europace/euv212. Epub 2015 Sep 15.
5
Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.MADIT-CRT 中的心脏再同步治疗的心脏和非心脏死亡率的风险因素及影响。
Europace. 2015 Dec;17(12):1816-22. doi: 10.1093/europace/euv201. Epub 2015 Jun 11.
6
Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.与仅接受植入式心律转复除颤器（ICD）治疗的窄QRS波心力衰竭患者相比，接受心脏再同步化治疗（CRT）联合ICD治疗的宽QRS波心力衰竭患者长期总体死亡率降低。
Europace. 2016 Sep;18(9):1374-82. doi: 10.1093/europace/euv347. Epub 2015 Nov 26.
7
Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.伴有中度肾功能障碍的轻度心力衰竭患者心脏再同步治疗的长期结果。
Circ Heart Fail. 2015 Jul;8(4):725-32. doi: 10.1161/CIRCHEARTFAILURE.115.002082. Epub 2015 Jun 2.
8
Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.植入式心脏复律除颤器治疗中房颤的作用：死亡、恰当及不恰当电击的危险因素
J Cardiovasc Electrophysiol. 2013 Oct;24(10):1116-22. doi: 10.1111/jce.12208. Epub 2013 Jul 25.
9
Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.女性与男性的心脏再同步治疗：来自国家心血管数据登记处的观察性比较疗效研究。
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S4-11. doi: 10.1161/CIRCOUTCOMES.114.001548. Epub 2015 Feb 24.
10
PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.PR 间期可预测非左束支传导阻滞患者的临床反应：多中心自动除颤器植入试验-心脏再同步治疗亚研究。
Circ Arrhythm Electrophysiol. 2014 Aug;7(4):645-51. doi: 10.1161/CIRCEP.113.001299. Epub 2014 Jun 24.